These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33395103)

  • 1. Agitation in schizophrenia: origins and evidence-based treatment.
    Citrome L
    Curr Opin Psychiatry; 2021 May; 34(3):216-221. PubMed ID: 33395103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative Approaches for Addressing Acute Agitation in Schizophrenia and Bipolar Disorder.
    Citrome L; Correll CU; San L; Zeller SL; Madden S; Gutierrez J; Lopez-Toledano M; Misra SN; Carrazana E; Rabinowicz AL
    Prim Care Companion CNS Disord; 2024 Jan; 26(1):. PubMed ID: 38301034
    [No Abstract]   [Full Text] [Related]  

  • 3. Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder.
    San L; Estrada G; Oudovenko N; Vieta E
    BMC Psychiatry; 2017 Apr; 17(1):126. PubMed ID: 28376877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Older and Newer Strategies for the Pharmacological Management of Agitation in Patients with Bipolar Disorder or Schizophrenia.
    Amodeo G; Fagiolini A; Sachs G; Erfurth A
    CNS Neurol Disord Drug Targets; 2017; 16(8):885-890. PubMed ID: 28933260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled loxapine: a new treatment for agitation in schizophrenia or bipolar disorder.
    Owen RT
    Drugs Today (Barc); 2013 Mar; 49(3):195-201. PubMed ID: 23527323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New formulations of olanzapine in the treatment of acute agitation].
    Bartkó G
    Neuropsychopharmacol Hung; 2006 Dec; 8(4):171-8. PubMed ID: 17211052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled loxapine for the urgent treatment of acute agitation associated with schizophrenia or bipolar disorder.
    Pollack CV
    Curr Med Res Opin; 2016 Jul; 32(7):1253-60. PubMed ID: 27121764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy review of inhaled loxapine for treatment of agitation.
    Currier G; Walsh P
    Clin Schizophr Relat Psychoses; 2013 Apr; 7(1):25-32. PubMed ID: 23538290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of typical and atypical antipsychotic medications in the management of agitation and aggression.
    Buckley PF
    J Clin Psychiatry; 1999; 60 Suppl 10():52-60. PubMed ID: 10340688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of self-administered inhaled loxapine (ADASUVE) in agitated patients outside the hospital setting: protocol for a phase IV, single-arm, open-label trial.
    Gil E; Garcia-Alonso F; Boldeanu A; Baleeiro Teixeira T;
    BMJ Open; 2018 Oct; 8(10):e020242. PubMed ID: 30282677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative delivery systems for agents to treat acute agitation: progress to date.
    Nordstrom K; Allen MH
    Drugs; 2013 Nov; 73(16):1783-92. PubMed ID: 24151084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-acting intramuscular second-generation antipsychotic drugs for acutely agitated patients with schizophrenia spectrum disorders. A systematic review and network meta-analysis.
    Paris G; Bighelli I; Deste G; Siafis S; Schneider-Thoma J; Zhu Y; Davis JM; Vita A; Leucht S
    Schizophr Res; 2021 Mar; 229():3-11. PubMed ID: 33607608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Inhaled Loxapine in Dual-Diagnosis Patients: A Case Series.
    Roncero C; Ros-Cucurull E; Grau-López L; Fadeuilhe C; Casas M
    Clin Neuropharmacol; 2016; 39(4):206-9. PubMed ID: 27015036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing Agitation Associated with Schizophrenia and Bipolar Disorder in the Emergency Setting.
    Zeller SL; Citrome L
    West J Emerg Med; 2016 Mar; 17(2):165-72. PubMed ID: 26973742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Old drug in new package promises to calm the agitated.
    Morrow T
    Manag Care; 2014 Apr; 23(4):50-1. PubMed ID: 24864536
    [No Abstract]   [Full Text] [Related]  

  • 16. The Management of Psychomotor Agitation Associated with Schizophrenia or Bipolar Disorder: A Brief Review.
    Pompili M; Ducci G; Galluzzo A; Rosso G; Palumbo C; De Berardis D
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33924111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerosolised antipsychotic assuages agitation: inhaled loxapine for agitation associated with schizophrenia or bipolar disorder.
    Citrome L
    Int J Clin Pract; 2011 Mar; 65(3):330-40. PubMed ID: 21199198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New medical approach to out-of-hospital treatment of psychomotor agitation in psychiatric patients: a report of 14 cases].
    Cester-Martínez A; Cortés-Ramas JA; Borraz-Clares D; Pellicer-Gayarre M
    Emergencias; 2017 Jun; 29(3):182-184. PubMed ID: 28825239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review.
    de Berardis D; Fornaro M; Orsolini L; Iasevoli F; Tomasetti C; de Bartolomeis A; Serroni N; Valchera A; Carano A; Vellante F; Marini S; Piersanti M; Perna G; Martinotti G; Di Giannantonio M
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual dexmedetomidine: repurposing an anesthetic as an anti-agitation agent.
    Faden J; Musselman M; Citrome L
    Expert Rev Neurother; 2023 Feb; 23(2):97-106. PubMed ID: 36707066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.